Preferred term | Patients with 1 or more event (N = 1752) n (%) | Patients with events occurring more than once n (%) |
---|---|---|
Any injection site-related AE | 92 (5.3) | 19 (20.7) |
Injection site pain | 50 (2.9) | 6 (12.0) |
Injection site reaction | 10 (0.6) | 1 (10.0) |
Injection site mass | 8 (0.5) | 3 (37.5) |
Injection site swelling | 8 (0.5) | 3 (37.5) |
Injection site induration | 6 (0.3) | 1 (16.7) |
Injection site nodule | 6 (0.3) | 2 (33.3) |
Injection site irritation | 5 (0.3) | 2 (40.0) |
Injection site abscess | 4 (0.2) | |
Injection site haemorrhage | 4 (0.2) | 1 (25.0) |
Injection site warmth | 3 (0.2) | |
Injection site erythema | 2 (0.1) | |
Injection site discolouration | 1 (0.1) | |
Injection site extravasation | 1 (0.1) | |
Injection site oedema | 1 (0.1) | |
Injection site paraesthesia | 1 (0.1) | |
Injection site rash | 1 (0.1) | 1 (100.0) |